Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Flu is arriving earlier than usual this year, with test positivity rates already far above where they were at this point in recent years. Experts are urging people to get vaccinated now, especially with a new mRNA flu vaccine available for adults 50 and older. The severity of the season remains to be seen, but the early uptick is a clear signal to act.
Flu season is knocking on the door earlier than usual this year. CDC data shows that about 3.6% of flu tests came back positive in early October 2026 — compared to just 0.6% at the same point last year — and outpatient visits for flu-like illness are climbing, particularly among children. Experts say the early signal is enough reason to get vaccinated without delay.
Adding a new wrinkle to this season: the FDA has approved the first-ever mRNA-based flu vaccine, now available to adults 50 and older. This comes amid a broader reshaping of federal vaccine policy under the Trump administration, which has placed greater emphasis on vaccine safety and injury reporting. Experts stress that serious vaccine reactions remain rare.
By the Numbers:
Why it matters: An early flu season can strain healthcare systems and catch people off guard. Getting vaccinated now — before the season peaks — gives the immune system the best chance to mount a strong defense. The arrival of an mRNA flu vaccine also marks a significant milestone in how we fight influenza going forward.